Table 2 Association of cardiometabolic markers with hepatic steatosis in population without obesity and diabetes.

CMI

3.865(2.302,6.491)

< 0.0001

3.868(2.269,6.592)

< 0.001

3.877(2.252,6.674)

< 0.001

Q1

ref

ref

ref

Q2

1.771(1.341,2.337)

< 0.001

1.819(1.342,2.465)

0.002

1.849(1.359,2.516)

0.003

Q3

3.937(2.393,6.477)

< 0.0001

3.936(2.349,6.597)

< 0.001

3.967(2.297,6.851)

< 0.001

P for trend

< 0.0001

< 0.0001

< 0.001

AIP

5.045(2.882,8.832)

< 0.0001

5.173(2.859,9.361)

< 0.001

5.261(2.818,9.819)

< 0.001

Q1

ref

ref

ref

Q2

1.574(1.149,2.156)

0.008

1.605(1.138,2.264)

0.013

1.648(1.152,2.358)

0.014

Q3

3.212(2.100,4.913)

< 0.0001

3.238(2.086,5.026)

< 0.001

3.255(2.031,5.216)

< 0.001

P for trend

< 0.0001

< 0.001

< 0.001

TyG

2.701(2.043,3.571)

< 0.0001

2.719(2.029,3.645)

< 0.0001

2.738(2.021,3.710)

< 0.001

Q1

ref

ref

ref

Q2

1.568(1.055,2.330)

0.029

1.707(1.104,2.641)

0.022

1.733(1.097,2.737)

0.026

Q3

3.530(2.355,5.290)

< 0.0001

3.606(2.376,5.473)

< 0.0001

3.689(2.363,5.760)

< 0.001

P for trend

< 0.0001

< 0.0001

< 0.001

eGDR

0.774(0.706,0.848)

< 0.0001

0.772(0.702,0.849)

< 0.001

0.771(0.696,0.854)

< 0.001

Q1

ref

ref

ref

Q2

0.545(0.322,0.921)

0.026

0.533(0.309,0.919)

0.028

0.542(0.318,0.926)

0.031

Q3

0.217(0.128,0.366)

< 0.0001

0.212(0.124,0.362)

< 0.001

0.217(0.127,0.373)

< 0.001

P for trend

< 0.0001

< 0.0001

< 0.001

FLI

1.041(1.030,1.052)

< 0.0001

1.041(1.029,1.053)

< 0.0001

1.041(1.028,1.054)

< 0.001

Q1

ref

ref

ref

Q2

1.911(1.069, 3.417)

0.031

1.916(1.015, 3.617)

0.046

1.929(0.977, 3.807)

0.056

Q3

2.507(1.242,6.284)

< 0.0001

2.786(1.263,7.221)

< 0.0001

2.695(1.997,7.816)

< 0.001

P for trend

1.041(1.030,1.052)

< 0.0001

1.041(1.029,1.053)

< 0.0001

1.041(1.028,1.054)

< 0.001